Rebecca Frey - Chief Executive Officer, Director at Yarrow Bioscience, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Rebecca Frey since 17 Nov 2025

Reported holdings for Rebecca Frey in Yarrow Bioscience, Inc.

Form 4 holding Chief Executive Officer, Director

Yarrow Bioscience, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
465,857
Estimated value
Report date
29 Oct 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Rebecca Frey in Yarrow Bioscience, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .